[ad_1] Ocriplasmin approved for treatment of symptomatic vitreomacular adhesion Ocriplasmin approved for treatment of symptomatic vitreomacular adhesion | Ophthalmology Ophthalmology | The U.S. Food and Drug Administration has approved Jetrea to treat symptomatic vitreomacular adhesion, according to a news release from ThromboGenics. The approval follows …